Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 50
Filter
Add more filters










Publication year range
1.
J Virol ; 94(15)2020 07 16.
Article in English | MEDLINE | ID: mdl-32404527

ABSTRACT

Orf virus (ORFV) represents a suitable vector for the generation of efficient, prophylactic antiviral vaccines against different pathogens. The present study investigated for the first time the therapeutic application of ORFV vector-based vaccines against tumors induced by cottontail rabbit papillomavirus (CRPV). ORFV-CRPV recombinants were constructed expressing the early CRPV gene E1, E2, E7, or LE6. In two independent experiments we used in total 23 rabbits which were immunized with a mixture of the four ORFV-CRPV recombinants or empty ORFV vector as a control 5 weeks after the appearance of skin tumors. For the determination of the therapeutic efficacy, the subsequent growth of the tumors was recorded. In the first experiment, we could demonstrate that three immunizations of rabbits with high tumor burden with the combined four ORFV-CRPV recombinants resulted in significant growth retardation of the tumors compared to the control. A second experiment was performed to test the therapeutic effect of 5 doses of the combined vaccine in rabbits with a lower tumor burden than in nonimmunized rabbits. Tumor growth was significantly reduced after immunization, and one vaccinated rabbit even displayed complete tumor regression until the end of the observation period at 26 weeks. Results of delayed-type hypersensitivity (DTH) skin tests suggest the induction of a cellular immune response mediated by the ORFV-CRPV vaccine. The data presented show for the first time a therapeutic potential of the ORFV vector platform and encourage further studies for the development of a therapeutic vaccine against virus-induced tumors.IMPORTANCE Viral vectors are widely used for the development of therapeutic vaccines for the treatment of tumors. In our study we have used Orf virus (ORFV) strain D1701-V for the generation of recombinant vaccines expressing cottontail rabbit papillomavirus (CRPV) early proteins E1, E2, LE6, and E7. The therapeutic efficacy of the ORFV-CRPV vaccines was evaluated in two independent experiments using the outbred CRPV rabbit model. In both experiments the immunization achieved significant suppression of tumor growth. In total, 84.6% of all outbred animals benefited from the ORFV-CRPV vaccination, showing reduction in tumor size and significant tumor growth inhibition, including one animal with complete tumor regression without recurrence.


Subject(s)
Cancer Vaccines/immunology , Cottontail rabbit papillomavirus/immunology , Neoplasms/therapy , Orf virus/immunology , Papillomavirus Infections/therapy , Viral Vaccines/immunology , Animals , Cancer Vaccines/genetics , Chlorocebus aethiops , Cottontail rabbit papillomavirus/genetics , Neoplasms/genetics , Neoplasms/immunology , Neoplasms/virology , Orf virus/genetics , Papillomavirus Infections/genetics , Papillomavirus Infections/immunology , Rabbits , Vero Cells , Viral Proteins/genetics , Viral Proteins/immunology , Viral Vaccines/genetics
2.
Vaccine ; 28(7): 1808-13, 2010 Feb 17.
Article in English | MEDLINE | ID: mdl-20018271

ABSTRACT

Both DNA and Orf virus (ORFV; Parapox virus) based vaccines have shown promise as alternatives for conventional vaccines in pigs against pseudorabies virus (PRV) infection causing Aujeszky's disease. In the present study we evaluated the efficacy of different prime-boost regimes in pigs in terms of immunogenicity and protection against challenge infection with PRV. The different prime-boost regimes consisted of the homologous prime-boost regimes (DNA followed by DNA or ORFV followed by ORFV) and the heterologous prime-boost regimes (DNA followed by ORFV and ORFV followed by DNA), all based on glycoprotein D (gD) of PRV. Moreover, we compared the efficacy of the different prime-boost regimes with the efficacy of a conventional modified live vaccine (MLV). The different prime-boost regimes resulted in different levels of immunity and protection against challenge infection. Most effective was the regime of priming with DNA vaccine followed by boosting with the ORFV based vaccine. This regime resulted in strong antibody responses, comparable to the antibody responses obtained after prime-boost vaccination with a conventional MLV vaccine. Also with regard to protection, the prime DNA-boost ORFV regime performed better than the other prime-boost regimes. This study demonstrates the potential of a heterologous prime-boost vaccination strategy against PRV based on a single antigen, and that in the natural host, the pig.


Subject(s)
Orf virus/immunology , Pseudorabies/prevention & control , Vaccines, DNA/immunology , Viral Envelope Proteins/immunology , Viral Vaccines/immunology , Animals , Antibodies, Neutralizing/blood , Antibodies, Neutralizing/immunology , Antibodies, Viral/blood , Antibodies, Viral/immunology , Antibody Formation , Cell Proliferation , Herpesvirus 1, Suid/immunology , Immunization, Secondary , Lymphocyte Activation , Pseudorabies/immunology , Swine
3.
Vet Rec ; 155(18): 553-8, 2004 Oct 30.
Article in English | MEDLINE | ID: mdl-15559987

ABSTRACT

Twenty-four calves were immunised four times with gE-deleted infectious bovine rhinotracheitis marker vaccines before being challenged with small doses of wild-type bovine herpesvirus type 1 (BHV-1). The repeated vaccinations induced strong immunity that prevented detectable virus replication and gE-seroconversion after the challenge infection in most of the calves. The hypervaccinated calves that shed virus after the challenge infection showed no delay in gE-seroconversion compared with unvaccinated control calves. Using a sensitive nested PCR, BHV-1 gE sequences could be detected in the trigeminal ganglia of several of the gE-seronegative, challenge-infected calves, possibly indicating the presence of wild-type BHV-1 DNA.


Subject(s)
Antibodies, Viral/blood , Cattle Diseases/prevention & control , Herpesviridae Infections/veterinary , Herpesvirus 1, Bovine/immunology , Viral Vaccines/immunology , Animals , Cattle , Cattle Diseases/immunology , DNA, Viral/analysis , DNA, Viral/isolation & purification , Herpesviridae Infections/immunology , Herpesviridae Infections/prevention & control , Polymerase Chain Reaction/methods , Polymerase Chain Reaction/veterinary , Random Allocation , Trigeminal Ganglion/virology , Vaccines, Inactivated , Viral Envelope Proteins , Viral Proteins , Viral Vaccines/administration & dosage , Virus Replication , Virus Shedding
4.
J Virol ; 78(15): 8085-93, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15254180

ABSTRACT

Parapoxviruses can be morphologically distinguished from other poxviruses in conventional negative staining electron microscopy (EM) by their ovoid appearance and the spiral tubule surrounding the virion's surface. However, this technique may introduce artifacts. We have examined Orf virus (ORFV; the prototype species of the Parapoxvirus genus) by cryoelectron microscopy (cryo-EM) and cryo-negative staining EM. From these studies we suggest that the shape and unique spiral tubule are authentic features of the parapoxviruses. We also constructed an ORFV mutant deleted of a gene encoding a 10-kDa protein, which is an orthologue of the vaccinia virus (VACV) 14-kDa fusion protein, and investigated its ultrastructure. This mutant virus multiplied slowly in permissive cells and produced infectious but morphologically aberrant particles. Mutant virions lacked the spiral tubule but displayed short disorganized tubules similar to those observed on the surface of VACV. In addition, thin extensions or loop-like structures were appended to the ORFV mutant particles. We suggest that these appended structures arise from a failure of the mutant virus particles to properly seal and that the sealing activity is dependent on the 10-kDa protein.


Subject(s)
Orf virus/ultrastructure , Viral Proteins/physiology , Animals , Cattle , Chlorocebus aethiops , Humans , Microscopy, Electron , Orf virus/genetics , Orf virus/physiology , Vero Cells , Virus Assembly
5.
J Gen Virol ; 84(Pt 5): 1111-1116, 2003 May.
Article in English | MEDLINE | ID: mdl-12692275

ABSTRACT

The present study provides for the first time an extended investigation of individual genes located at the near-terminal right end of the genome of parapoxvirus bovis 1, Bovine papular stomatitis virus (BPSV) strain B177 and Orf virus (ORFV). Comparison of the respective DNA sequences of ORFV strain D1701 (9.9 kbp) and BPSV B177 (7.7 kbp) revealed a very similar organization of closely related genes transcribed in a rightward orientation. The most salient findings of this study were: (i) the absence of the ORFV-specific vascular endothelial growth factor (VEGF-E) gene in the BPSV isolate; (ii) the presence of an interleukin-10 (IL-10) orthologue; and (iii) the detection of three new genes encoding ankyrin-repeat-containing polypeptides. These results not only contribute to potential improvements of future molecular differentiation between the parapoxvirus species, but also shed new light on different pathobiologies among parapoxviruses.


Subject(s)
Genetic Variation , Genome, Viral , Orf virus/genetics , Parapoxvirus/genetics , Viral Proteins/genetics , Amino Acid Sequence , Animals , Cattle , Interleukin-10/chemistry , Interleukin-10/genetics , Interleukin-10/metabolism , Molecular Sequence Data , Sequence Analysis, DNA , Viral Proteins/chemistry , Viral Proteins/metabolism
6.
J Gen Virol ; 83(Pt 11): 2845-2855, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12388821

ABSTRACT

The first report of a vascular endothelial growth factor (VEGF)-like gene in Orf virus included the surprising observation that the genes from two isolates (NZ2 and NZ7) shared only 41.1% amino acid sequence identity. We have examined this sequence disparity by determining the VEGF gene sequence of 21 isolates of Orf virus derived from diverse sources. Most isolates carried NZ2-like VEGF genes but their predicted amino acid sequences varied by up to 30.8% with an average amino acid identity between pairs of NZ2-like sequences of 86.1%. This high rate of sequence variation is more similar to interspecies than intraspecies variability. In contrast, only three isolates carried an NZ7-like VEGF gene and these varied from the NZ7 sequence by no more than a single nucleotide. The VEGF family are ligands for a set of tyrosine kinase receptors. The viral VEGFs are unique among the family in that they recognize VEGF receptor 2 (VEGFR-2) but not VEGFR-1 or VEGFR-3. Comparisons of the viral VEGFs with other family members revealed some correlations between conserved residues and the ability to recognize specific VEGF receptors. Despite the sequence variations, structural predictions for the viral VEGFs were very similar to each other and to the structure determined by X-ray crystallography for human VEGF-A. Structural modelling also revealed that a groove seen in the VEGF-A homodimer and believed to play a role in its binding to VEGFR-1 is blocked in the viral VEGFs. This may contribute to the inability of the viral VEGFs to bind VEGFR-1.


Subject(s)
Conserved Sequence , Endothelial Growth Factors , Endothelial Growth Factors/genetics , Genetic Variation , Intercellular Signaling Peptides and Proteins , Lymphokines , Orf virus/genetics , Sheep Diseases/virology , Viral Proteins/genetics , Amino Acid Motifs , Amino Acid Sequence , Animals , Binding Sites , Cattle , Cell Line , Crystallography, X-Ray , Endothelial Growth Factors/chemistry , Endothelial Growth Factors/metabolism , Intercellular Signaling Peptides and Proteins/chemistry , Intercellular Signaling Peptides and Proteins/genetics , Intercellular Signaling Peptides and Proteins/metabolism , Lymphokines/chemistry , Lymphokines/genetics , Lymphokines/metabolism , Models, Molecular , Molecular Sequence Data , Protein Structure, Tertiary , Sequence Homology, Amino Acid , Sheep , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factor Receptor-1 , Vascular Endothelial Growth Factor Receptor-2 , Vascular Endothelial Growth Factor Receptor-3 , Vascular Endothelial Growth Factors , Viral Proteins/chemistry , Viral Proteins/metabolism
7.
J Gen Virol ; 83(Pt 5): 1043-1048, 2002 May.
Article in English | MEDLINE | ID: mdl-11961258

ABSTRACT

The present study is the first report on the functional activity of a parapoxvirus-encoded dUTPase. The dUTPase gene of the attenuated orf virus (ORFV), strain D1701, was expressed as a bacterial thioredoxin fusion protein. In vitro assays showed that ORFV dUTPase was highly specific for dUTP as substrate. The enzyme was active over a broad pH range (pH 6.0-9.0), with maximal enzymatic activity at pH 7.0 in the presence of Mg(2+) cations. Kinetic studies of the recombinant ORFV dUTPase revealed an apparent K(m) of 4.0 microM, which is more similar to that of the mammalian or African swine fever virus enzyme than to the K(m) of vaccinia virus dUTPase. Enzyme activity was also found with purified ORFV particles, indicating its virion association.


Subject(s)
Orf virus/enzymology , Pyrophosphatases/genetics , Deoxyuracil Nucleotides/metabolism , Orf virus/genetics
8.
Article in English | MEDLINE | ID: mdl-11911596

ABSTRACT

Viruses of the genus parapoxvirus from the family poxviridae cause widespread but localized diseases of small and large ruminants. The economically most important disease is contagious pustular dermatitis or contagious ecthyma among sheep and goats, often simply called orf. The parapoxviruses (PPV) can be transmitted to man leading to localized lesions that are named pseudocowpox or milkers' node as being mostly restricted to the hands and fingers. In cattle two forms of PPV manifestation are commonly observed, the bovine papular stomatitis in young calves and the occurrence of lesions at the udder of cows. We here report about the recent efforts in molecular characterization of orf viruses and the state of the art about the generation of orf virus recombinants. In addition the current knowledge on immune responses against orf viruses and some new data on the behaviour of orf virus recombinants under non-permissive conditions are reported.


Subject(s)
Parapoxvirus/genetics , Poxviridae Infections/virology , Animals , Cattle , Genome, Viral , Goats , Humans , Sheep , Zoonoses
9.
Immunology ; 101(3): 378-87, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11106942

ABSTRACT

The induction of porcine cytokines, which are believed to be important for the regulation of T helper (Th)1- and Th2-specific immune responses of pigs, was analysed after in vitro restimulation with a herpesvirus, Suid herpes 1 (pseudorabies virus [PRV]), in peripheral blood mononuclear cells (PBMC). To this end, quantitative, competitive reverse transcription-polymerase chain reaction (RT-qcPCR) was established using constructed heterologous DNA MIMICS, which contain cytokine- or glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-specific primer-binding sites. This is a simple method that allows reliable determination of the differing regulation of cytokine mRNAs specific for porcine interleukin (IL)-2, -4 and -10, interferon gamma (IFN-gamma) and the housekeeping gene, GAPDH, as an endogenous control. PBMC derived from naive (innate response) and PRV-primed (memory response) outbred swine were analysed comparatively. The results demonstrated that restimulation with PRV significantly enhanced the transcription of Th1-type cytokines (IL-2 and IFN-gamma) but not of Th2-type cytokines (IL-4 and IL-10). This virus-specific cytokine response was only found with PBMC from swine protected against lethal PRV challenge infection, but not with naive PBMC or with PBMC from pigs immunized with plasmid DNA encoding PRV glycoprotein gC. Notably, PBMC derived from immune and naive pigs constitutively produced relatively high amounts of IL-10-specific mRNA, exceeding that of GAPDH mRNA, independently of the addition of viral antigen or the mitogen concanavalin A (Con A). The results of this work should help to provide a better understanding of the effector cell/cytokine network response to infection with, or vaccination against, PRV. Additionally, the simple, reliable and sensitive RT-qcPCR, when used to determine the porcine cytokine pattern, might be of prognostic value for the induction of protective immunity.


Subject(s)
Cytokines/biosynthesis , Pseudorabies Vaccines/immunology , Pseudorabies/prevention & control , Swine Diseases/prevention & control , Th1 Cells/immunology , Animals , Cell Culture Techniques , Concanavalin A/immunology , Cytokines/genetics , Herpesvirus 1, Suid/immunology , Immunization , Leukocytes, Mononuclear/immunology , Pseudorabies/immunology , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Swine , Swine Diseases/immunology , Transcription, Genetic , Vaccines, DNA/immunology
10.
11.
Berl Munch Tierarztl Wochenschr ; 113(2): 41-5, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10726360

ABSTRACT

For in vivo determination of innate and memory immune reactions we have implanted sterile gelatin sponges subcutaneously in swine for the monitoring of the following immunological parameters: 1. Analysis of local cell population phenotypes after vascularization of the gelatin sponges using flow cytometry. 2. Comparative analysis of sponge-infiltrating cells after loading with viral antigen in primed as well as naive animals. 3. Performance of reverse transcription quantitative competitive PCR (RT-qcPCR) for the detection of porcine cytokine mRNA indicative for IFN-gamma, IL-2, IL-4, IL-8 and IL-10. The in vitro analysis, e.g. by re-exposure to viral antigens, allows the determination of cytokine reaction patterns of sponge derived cells, draining lymph node cells as well as PBMC of the same individual. Studies of innate reactions and modulation of cellular infiltration in transplanted gelatin sponges are possible. Functional assays, e.g. cell-mediated cytotoxicity, antigen specific cell proliferation, using sponge-derived cells will provide additional information about the suitability of the model for example in vaccine potency tests.


Subject(s)
Cytokines/genetics , Gelatin , Implants, Experimental , Lymphocytes/immunology , Swine/immunology , Animals , Herpesvirus 1, Suid/immunology , Immunity, Cellular , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Transcription, Genetic
12.
J Virol ; 74(4): 1752-60, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10644346

ABSTRACT

High titers of virus-neutralizing antibodies directed against glycoprotein gC of Pseudorabies virus (PRV) (Suid herpesvirus 1) are generally observed in the serum of immunized pigs. A known function of the glycoprotein gC is to mediate attachment of PRV to target cells through distinct viral heparin-binding domains (HBDs). Therefore, it was suggested that the virus-neutralizing activity of anti-PRV sera is directed against HBDs on gC. To address this issue, sera with high virus-neutralizing activity against gC were used to characterize the anti-gC response. Epitope mapping demonstrated that amino acids of HBDs are part of an antigenic antibody binding domain which is located in the N-terminal part of gC. Binding of antibodies to this antigenic domain of gC was further shown to interfere with the viral attachment. Therefore, these results show that the viral HBDs are accessible targets for the humoral anti-PRV response even after tolerance induction against self-proteins, which utilize similar HBDs to promote host protein-protein interactions. The findings indicate that the host's immune system can specifically block the attachment function of PRV gC. Since HBDs promote the attachment of a number of herpesviruses, the design of future antiherpesvirus vaccines should aim to induce a humoral immune response that prevents HBD-mediated viral attachment.


Subject(s)
Antibodies, Viral/immunology , Herpesvirus 1, Suid/immunology , Viral Envelope Proteins/immunology , Amino Acid Sequence , Animals , Binding Sites , Cattle , Cell Line , Consensus Sequence , Epitopes, B-Lymphocyte/immunology , Herpesvirus 1, Suid/genetics , Herpesvirus 1, Suid/metabolism , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Neutralization Tests , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Swine , Swine, Miniature , Viral Envelope Proteins/genetics , Viral Envelope Proteins/metabolism
13.
J Biotechnol ; 73(2-3): 235-42, 1999 Aug 20.
Article in English | MEDLINE | ID: mdl-10486932

ABSTRACT

Parapoxvirus (PPV) represents a genus of the poxviridae, and particularly PPV ovis (Orf virus, OV) seems to offer several potential advantages for the use of vector vaccine. Therefore, we started to investigate the genome of the highly attenuated OV strain D1701, which was only poorly characterised until now. Due to recombination of non-homologous sequences, part of the right hand end of the D1701 genome was duplicated and translocated to the opposite end of the genome. As a consequence gene deletion had occurred and the inverted terminal repeat region is increased. Results are described to identify viral genes, which are non-essential for virus replication and potentially influence viral pathogenesis, virulence, and host immunity. In more detail, we analysed the expression and functional activity of the OV-specific vascular endothelial growth factor (VEGF) gene homologue. Finally the construction and production of a D1701 mutant lacking the VEGF gene homologue is reported.


Subject(s)
Genetic Vectors , Parapoxvirus/genetics , Parapoxvirus/immunology , Animals , Biotechnology , Chromosome Mapping , Endothelial Growth Factors/genetics , Gene Deletion , Genome, Viral , Humans , Lymphokines/genetics , Orf virus/genetics , Orf virus/immunology , Orf virus/pathogenicity , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/genetics , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
14.
J Virol ; 73(8): 6251-6, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10400715

ABSTRACT

Borna disease virus (BDV) causes acute and persistent infections in various vertebrates. During recent years, BDV-specific serum antibodies, BDV antigen, and BDV-specific nucleic acid were found in humans suffering from psychiatric disorders. Furthermore, viral antigen was detected in human autopsy brain tissue by immunohistochemical staining. Whether BDV infection can be associated with psychiatric disorders is still a matter of debate; no direct evidence has ever been presented. In the present study we report on (i) the detection of BDV-specific nucleic acid in human granulocyte cell fraction from three different psychiatric patients and (ii) the isolation of infectious BDV from these cells obtained from a patient with multiple psychiatric disorders. In leukocyte preparations other than granulocytes, either no BDV RNA was detected or positive PCR results were obtained only if there was at least 20% contamination with granulocytes. Parts of the antigenome of the isolated virus were sequenced, demonstrating the close relationship to the prototype BDV strains (He/80 and strain V) as well as to other human virus sequences. Our data provide strong evidence that cells in the granulocyte fraction represent the major if not the sole cell type harboring BDV-specific nucleic acid in human blood and contain infectious virus. In contrast to most other reports of putative human isolates, where sequences are virtually identical to those of the established laboratory strains, this isolate shows divergence in the region previously defined as variable in BDV from naturally infected animals.


Subject(s)
Antibodies, Viral/immunology , Borna disease virus/genetics , Borna disease virus/immunology , Granulocytes/virology , Mental Disorders/virology , RNA Virus Infections/virology , Viral Proteins/genetics , Borna disease virus/isolation & purification , Borna disease virus/pathogenicity , Cell Fractionation , Granulocytes/immunology , Humans , Mental Disorders/immunology , RNA, Viral/analysis , Sequence Analysis, RNA
15.
J Clin Microbiol ; 37(8): 2498-507, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10405392

ABSTRACT

In the present study, we report for the first time on the detection of bovine herpesvirus type 1 (BHV-1) in whole-blood samples derived from naturally infected cattle. Sensitive PCR assays specific for glycoprotein B (gB), gC, and gE of BHV-1 allow the detection of one BHV-1 DNA copy in 10(5) to 10(7) peripheral blood leukocytes (PBLs). The incidence of BHV-1-positive PBLs in naturally infected cattle appears to be quite high (92.2% positive PBLs among all samples tested), although in most cases only between 10(-5) and 10(-7) positive leukocytes were present. The results demonstrate that the viral DNA is detectable not only in the peripheral blood of acutely infected animals but, more importantly, also in the peripheral blood of subclinically infected cattle. The gE-specific PCR described in the report allows discrimination between wild-type (WT) virus-infected and vaccinated animals, which is of importance for control programs that use the recently introduced vaccination strategy with a gE-negative virus. The results further show that doubtful serological results can be verified or falsified and that individual animals can be monitored for the presence or absence of WT BHV-1 or gE-negative virus in cattle herds. The PCR protocols allow the detection of BHV-1 prior to seroconversion or in BHV-1-seronegative cattle. Finally, the results indicate the simultaneous presence of WT and gE-negative vaccine virus in the PBLs of several cattle. Therefore, investigations of viremia in naturally and experimentally infected cattle and on the identification of infected cell types of bovine PBLs can be now performed.


Subject(s)
Cattle Diseases/virology , Herpesviridae Infections/virology , Herpesvirus 1, Bovine/genetics , Herpesvirus 1, Bovine/isolation & purification , Viral Envelope Proteins/genetics , Animals , Cattle , Cattle Diseases/blood , Herpesviridae Infections/blood , Molecular Sequence Data , Polymerase Chain Reaction/methods , Sensitivity and Specificity , Viral Proteins
16.
EMBO J ; 18(2): 363-74, 1999 Jan 15.
Article in English | MEDLINE | ID: mdl-9889193

ABSTRACT

The different members of the vascular endothelial growth factor (VEGF) family act as key regulators of endothelial cell function controlling vasculogenesis, angiogenesis, vascular permeability and endothelial cell survival. In this study, we have functionally characterized a novel member of the VEGF family, designated VEGF-E. VEGF-E sequences are encoded by the parapoxvirus Orf virus (OV). They carry the characteristic cysteine knot motif present in all mammalian VEGFs, while forming a microheterogenic group distinct from previously described members of this family. VEGF-E was expressed as the native protein in mammalian cells or as a recombinant protein in Escherichia coli and was shown to act as a heat-stable, secreted dimer. VEGF-E and VEGF-A were found to possess similar bioactivities, i.e. both factors stimulate the release of tissue factor (TF), the proliferation, chemotaxis and sprouting of cultured vascular endothelial cells in vitro and angiogenesis in vivo. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation and a biphasic rise in free intracellular Ca2+ concentration, whilst in contrast to VEGF-A, VEGF-E did not bind to VEGF receptor-1 (Flt-1). VEGF-E is thus a potent angiogenic factor selectively binding to VEGF receptor-2. These data strongly indicate that activation of VEGF receptor-2 alone can efficiently stimulate angiogenesis.


Subject(s)
Endothelial Growth Factors/genetics , Endothelial Growth Factors/physiology , Lymphokines/genetics , Lymphokines/physiology , Orf virus/genetics , Proto-Oncogene Proteins/physiology , Receptor Protein-Tyrosine Kinases/physiology , Receptors, Growth Factor/physiology , Viral Proteins/genetics , Viral Proteins/physiology , Amino Acid Sequence , Animals , Base Sequence , COS Cells , Cell Line , DNA Primers/genetics , Escherichia coli/genetics , Gene Expression , Genes, Viral , Humans , Molecular Sequence Data , Neovascularization, Physiologic/genetics , Rabbits , Receptors, Vascular Endothelial Growth Factor , Recombinant Proteins/genetics , Sequence Homology, Amino Acid , Signal Transduction , Thromboplastin/metabolism , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factor Receptor-1 , Vascular Endothelial Growth Factors
17.
Virus Res ; 56(1): 53-67, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9784065

ABSTRACT

The orf virus (OV) strain D1701 belongs to the genetically heterogenous parapoxvirus (PPV) genus of the family Poxviridae. The attenuated OV D1701 has been licensed as a live vaccine against contagious ecthyma in sheep. Detailed knowledge on the genetic structure and organization of this PPV vaccine strain is an important prerequisite to reveal possible genetic mechanisms of PPV attenuation. The present study demonstrates a genomic map of the approximately 158 kbp DNA of OV D1701 established by hybridization studies of cloned restriction fragments covering the complete viral genome. The results show an enlargement of the inverted terminal repeats (ITR) to up to 18 kbp due to recombination between nonhomologous sequences during cell culture adaptation. DNA sequencing of the region adjacent to the ITR junction revealed the absence of one open reading frame designated E2L. In contrast to a transposition-deletion variant of the New Zealand OV strain NZ2 (Fleming et al., 1995) the two genes E3L (a homologue of dUTPase) and G1L neighbouring E2L are retained in OV D1701. DNA and RNA analyses proved the presence of E2L gene in wild-type OV isolated directly from scab material. The data presented indicate that the E2L gene is nonessential for virus replication in vitro and in vivo, and may represent one important viral gene in determining virulence and pathogenesis of OV.


Subject(s)
Parapoxvirus/genetics , Viral Vaccines/genetics , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cattle , Cell Line , Chromosome Mapping , DNA, Viral/analysis , Gene Deletion , Genes, Viral/genetics , Molecular Sequence Data , Open Reading Frames , Orf virus/genetics , Orf virus/immunology , Parapoxvirus/immunology , Sequence Homology , Sheep , Vaccines, Attenuated/genetics , Vaccines, Attenuated/immunology , Viral Vaccines/immunology , Virus Replication
19.
Cytokine ; 10(4): 241-8, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9617567

ABSTRACT

In canine peripheral blood mononuclear cells (PBMC) the mRNAs coding for both subunits of canine interleukin 12 (IL-12) were identified using reverse transcription polymerase chain reaction (RT-PCR). Stimulation of canine PBMC with Staphylococcus aureus strain Cowan plus Concanavalin A for 5 h resulted in significant mRNA synthesis. Likewise, inactivated vaccinia virus induced IL-12 mRNA synthesis, however with different kinetics. The complete nucleotide sequence for both IL-12 subunits was determined using rapid amplification of cDNA ends (RACE)-PCR and cloning of amplified specific cDNAs. Computer-aided amino acid (aa) sequence comparison of both canine IL-12 subunits revealed more than 80% identity with the amino acid sequences of six other mammalian species. Closest relationship was found to human, porcine, bovine and cervine IL-12. However, no reactivity was found with antibodies directed against human IL-12, when supernatants of stimulated canine PBMC were tested. Supernatants of canine PBMC stimulated for IL-12 release also induced interferon gamma (IFN-gamma) mRNA as detectable by RT-PCR; however, it was not clear whether IFN-gamma mRNA synthesis was due to an IL-12 specific effect or other stimuli. As to the stimulating effect of IL-12 on canine IFN-gamma mRNA synthesis, recombinant human IL-12 was found to be a good inducer. Since IL-12 is regarded a major regulatory molecule of T-cell-mediated immune response and cell growth our work on the cloning and sequencing of this cytokine from dogs lays the basis for future investigations on the biological and possible therapeutic role of canine IL-12.


Subject(s)
Dogs/genetics , Interleukin-12/genetics , Amino Acid Sequence , Animals , Base Sequence , Cattle , Cloning, Molecular , Concanavalin A/pharmacology , DNA, Complementary , Dogs/blood , Enzyme-Linked Immunosorbent Assay , Female , Humans , Interferon-gamma/immunology , Interleukin-12/analysis , Male , Molecular Sequence Data , Polymerase Chain Reaction , RNA, Messenger , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Staphylococcus aureus/immunology
20.
J Virol ; 72(6): 4866-73, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9573253

ABSTRACT

Pseudorabies virus (PRV; suid herpesvirus 1) infection causes heavy economic losses in the pig industry. Therefore, vaccination with live attenuated viruses is practiced in many countries. This vaccination was demonstrated to induce extrathymic virus-specific memory CD4+CD8+ T lymphocytes. Due to their major histocompatibility complex (MHC) class II-restricted proliferation, it is generally believed that these T lymphocytes function as memory T-helper cells. To directly prove this hypothesis, 15-amino-acid, overlapping peptides of the viral glycoprotein gC were used for screening in proliferation assays with peripheral blood mononuclear cells of vaccinated d/d haplotype inbred pigs. In these experiments, two naturally processed T-cell epitopes (T1 and T2) which are MHC class II restricted were identified. It was shown that extrathymic CD4+CD8+ T cells are the T-lymphocyte subpopulation that responds to epitope T2. In addition, we were able to show that cytokine secretion can be induced in these T cells through recall with inactivated PRV and demonstrated that activated PRV-primed CD4+CD8+ T cells are able to induce PRV-specific immunoglobulin synthesis by PRV-primed, resting B cells. Taken together, these results demonstrate that the glycoprotein gC takes part in the priming of humoral anti-PRV memory responses. The experiments identified the first T-cell epitopes so far known to induce the generation of virus-specific CD4+CD8+ memory T lymphocytes and showed that CD4+CD8+ T cells are memory T-helper cells. Therefore, this study describes the generation of virus-specific CD4+CD8+ T cells, which is observed during vaccination, as a part of the potent humoral anti-PRV memory response induced by the vaccine.


Subject(s)
Cytotoxicity, Immunologic , Herpesvirus 1, Suid/immunology , Pseudorabies/immunology , Th1 Cells/immunology , Th2 Cells/immunology , Thymus Gland/immunology , Viral Vaccines/immunology , Animals , CD4 Antigens/immunology , CD8 Antigens/immunology , Immunologic Memory , Pseudorabies/prevention & control , Swine , Th1 Cells/cytology , Th2 Cells/cytology , Thymus Gland/cytology , Viral Vaccines/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...